FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033667097> ?p ?o ?g. }

• W3033667097 endingPage "2684" @default.
• W3033667097 startingPage "2672" @default.
• W3033667097 abstract "Therapy with irreversible Bruton's tyrosine kinase inhibitor ibrutinib in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) is associated with bleeding.To propose the predictive markers of such bleeding, as well as mechanisms responsible for decreased bleeding at later therapy stages.We investigate platelet functional activity in 50 CLL and 16 MCL patients on ibrutinib using flow cytometry and light transmission aggregometry.Prior to treatment, both patient groups had decreased platelet counts; impaired aggregation with adenosine diphosphate (ADP); and decreased binding of CD62P, PAC1, and annexin V upon stimulation. Bleeding in patients treated with ibrutinib was observed in 28 (56%) CLL patients, who had decreased aggregation with ADP and platelet count before therapy. Their platelet count on therapy did not change, platelet aggregation with ADP steadily improved, and aggregation with collagen first decreased and then increased in anticorrellation with bleeding. Bleeding in MCL was observed in 10 (62%) patients, who had decreased dense granule release before therapy. ADP and ristocetin induced platelet aggregation in ibrutinib-treated MCL patients increased on therapy, while collagen-induced aggregation evolved similarly to CLL patients.Our results suggest that ibrutinib-dependent bleeding in CLL patients involves three mechanisms: decreased platelet count (the most important discriminator between bleeding and non-bleeding patients), impaired platelet response to ADP caused by CLL, and inhibition by ibrutinib. Initially, ibrutinib shifts the balance to bleeding, but then it is restored because of the improved response to ADP." @default.
• W3033667097 created "2020-06-12" @default.
• W3033667097 creator A5024663060 @default.
• W3033667097 creator A5026762150 @default.
• W3033667097 creator A5030091320 @default.
• W3033667097 creator A5044431391 @default.
• W3033667097 creator A5050745178 @default.
• W3033667097 creator A5058001042 @default.
• W3033667097 creator A5071809163 @default.
• W3033667097 creator A5075010755 @default.
• W3033667097 creator A5077089081 @default.
• W3033667097 creator A5086377770 @default.
• W3033667097 creator A5087531377 @default.
• W3033667097 creator A5087737205 @default.
• W3033667097 date "2020-10-01" @default.
• W3033667097 modified "2023-10-16" @default.
• W3033667097 title "Platelet function and bleeding in chronic lymphocytic leukemia and mantle cell lymphoma patients on ibrutinib" @default.
• W3033667097 cites W1567813092 @default.
• W3033667097 cites W2025707347 @default.
• W3033667097 cites W2054220445 @default.
• W3033667097 cites W2063262989 @default.
• W3033667097 cites W2115506924 @default.
• W3033667097 cites W2142099365 @default.
• W3033667097 cites W2143032169 @default.
• W3033667097 cites W2149700343 @default.
• W3033667097 cites W2158602811 @default.
• W3033667097 cites W2194813815 @default.
• W3033667097 cites W2256135779 @default.
• W3033667097 cites W2260369425 @default.
• W3033667097 cites W2315414648 @default.
• W3033667097 cites W2558905818 @default.
• W3033667097 cites W2565882929 @default.
• W3033667097 cites W2575232065 @default.
• W3033667097 cites W2604832096 @default.
• W3033667097 cites W2770172979 @default.
• W3033667097 cites W2885033960 @default.
• W3033667097 cites W2889246241 @default.
• W3033667097 cites W2895139286 @default.
• W3033667097 cites W2902815908 @default.
• W3033667097 cites W2919444768 @default.
• W3033667097 cites W2931907172 @default.
• W3033667097 cites W2938629237 @default.
• W3033667097 cites W2997844978 @default.
• W3033667097 cites W3012011926 @default.
• W3033667097 doi "https://doi.org/10.1111/jth.14943" @default.
• W3033667097 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32511880" @default.
• W3033667097 hasPublicationYear "2020" @default.
• W3033667097 type Work @default.
• W3033667097 sameAs 3033667097 @default.
• W3033667097 citedByCount "16" @default.
• W3033667097 countsByYear W30336670972020 @default.
• W3033667097 countsByYear W30336670972021 @default.
• W3033667097 countsByYear W30336670972022 @default.
• W3033667097 countsByYear W30336670972023 @default.
• W3033667097 crossrefType "journal-article" @default.
• W3033667097 hasAuthorship W3033667097A5024663060 @default.
• W3033667097 hasAuthorship W3033667097A5026762150 @default.
• W3033667097 hasAuthorship W3033667097A5030091320 @default.
• W3033667097 hasAuthorship W3033667097A5044431391 @default.
• W3033667097 hasAuthorship W3033667097A5050745178 @default.
• W3033667097 hasAuthorship W3033667097A5058001042 @default.
• W3033667097 hasAuthorship W3033667097A5071809163 @default.
• W3033667097 hasAuthorship W3033667097A5075010755 @default.
• W3033667097 hasAuthorship W3033667097A5077089081 @default.
• W3033667097 hasAuthorship W3033667097A5086377770 @default.
• W3033667097 hasAuthorship W3033667097A5087531377 @default.
• W3033667097 hasAuthorship W3033667097A5087737205 @default.
• W3033667097 hasConcept C126322002 @default.
• W3033667097 hasConcept C170493617 @default.
• W3033667097 hasConcept C203014093 @default.
• W3033667097 hasConcept C2777399203 @default.
• W3033667097 hasConcept C2777525834 @default.
• W3033667097 hasConcept C2777938653 @default.
• W3033667097 hasConcept C2778461978 @default.
• W3033667097 hasConcept C2779338263 @default.
• W3033667097 hasConcept C2779878957 @default.
• W3033667097 hasConcept C2993802102 @default.
• W3033667097 hasConcept C3018697912 @default.
• W3033667097 hasConcept C42362537 @default.
• W3033667097 hasConcept C71924100 @default.
• W3033667097 hasConcept C89560881 @default.
• W3033667097 hasConcept C90059517 @default.
• W3033667097 hasConcept C90924648 @default.
• W3033667097 hasConceptScore W3033667097C126322002 @default.
• W3033667097 hasConceptScore W3033667097C170493617 @default.
• W3033667097 hasConceptScore W3033667097C203014093 @default.
• W3033667097 hasConceptScore W3033667097C2777399203 @default.
• W3033667097 hasConceptScore W3033667097C2777525834 @default.
• W3033667097 hasConceptScore W3033667097C2777938653 @default.
• W3033667097 hasConceptScore W3033667097C2778461978 @default.
• W3033667097 hasConceptScore W3033667097C2779338263 @default.
• W3033667097 hasConceptScore W3033667097C2779878957 @default.
• W3033667097 hasConceptScore W3033667097C2993802102 @default.
• W3033667097 hasConceptScore W3033667097C3018697912 @default.
• W3033667097 hasConceptScore W3033667097C42362537 @default.
• W3033667097 hasConceptScore W3033667097C71924100 @default.
• W3033667097 hasConceptScore W3033667097C89560881 @default.
• W3033667097 hasConceptScore W3033667097C90059517 @default.

• next